Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination

Gumber, Leher; Gomez, Nancy; Hopkins, Georgina; Tucis, Davis; Bartlett, Laura; Ayling, Kieran; Vedhara, Kavita; Steers, Graham; Chakravorty, Mithun; Rutter, Megan; Jackson, Hannah; Tighe, Patrick; Ferraro, Alastair; Power, Sheila; Pradère, Marie-Josèphe; Onion, David; Lanyon, Peter C.; Pearce, Fiona A; Fairclough, Lucy

doi:10.1093/rheumatology/keac574

All Outputs (2)

Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study (2023)
Journal Article

Objective: Antibody responses to coronavirus disease 2019 (COVID-19) vaccines are reduced among immunocompromised patients but are not well quantified among people with rare disease. We conducted an observational study to evaluate the antibody respon... Read More about Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study.

Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination (2022)
Journal Article

Objectives: COVID-19 vaccine responses in rare autoimmune rheumatic diseases (RAIRD) remain poorly understood, in particular there is little known about whether people develop effective T-cell responses. We conducted a prospective cohort study to eva... Read More about Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination.